FDA approves selinexor for relapsed/refractory diffuse large B-cell lymphoma

FDA approves selinexor for relapsed/refractory diffuse large B-cell lymphoma

http://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-selin...

Source: FDA Center for Drug Evaluation and Research - What's New - June 22, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

More News: Drugs & Pharmacology | Lymphoma